Related Experiment Video
Updated: May 3, 2026

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody
Published on: May 16, 2020
The unexpected side effects and safety of therapeutic monoclonal antibodies
1University of Sun Yat-Sen, Sun Yat-Sen Memorial Hospital, Department of Pediatric Hematology/Oncology, Guang Zhou, China.
Abstract:
Monoclonal antibodies (MAbs) have ushered in a new era of targeted therapy, particularly in the fields of immunotherapy and oncology. MAbs have been developed from murine antibodies to fully human antibodies, with significant improvements in immunogenicity and safety. Nevertheless, the safety of these agents is being paid close attention with relative side effects being reported. These side effects have caused many researchers' confidence in MAbs to waver. This review comprehensively summarizes the side effects of MAbs in clinical use, highlighting the prevention and management of adverse effects. Although many MAbs are well tolerated, with new MAbs continuing to be innovated, it is hard to ensure that every fresh stock of MAbs is absolutely safe. The clinical use of MAbs will face greater challenges in the future. Physicians should be on the alert for lethal side effects and treat them as soon as possible.
More Related Videos
06:37Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety
Published on: September 15, 2023
08:53In Vivo Immunofluorescence Localization for Assessment of Therapeutic and Diagnostic Antibody Biodistribution in Cancer Research
Published on: September 16, 2019
Related Concept Videos
Therapeutic Drug Monitoring: Affecting Factors
Targeted Cancer Therapies
There are several types of targeted therapies against...
Therapeutic Drug Monitoring: Overview and Classification
Cross-reactivity
Hybridoma Technology
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Effects of Chemicals: Overview